Literature DB >> 32512162

Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes.

Nicholas Blixt1, Andrew Norton2, Anqi Zhang3, Conrado Aparicio3, Hari Prasad4, Rajaram Gopalakrishnan4, Eric D Jensen4, Kim C Mansky5.   

Abstract

Osteoclasts are multinuclear cells that resorb bone. Osteoclast differentiation is regulated by multiple transcription factors which may be acting in a single or multiple factor complex to regulate gene expression. Myocyte enhancer factor 2 (MEF2) is a family of transcription factors whose role during osteoclast differentiation has not been well characterized. Because MEF2A and MEF2D are the family members most highly expressed during osteoclast differentiation, we created conditional knockout mice models for MEF2A and/or MEF2D. In vitro cultures of A- and D-KO osteoclasts were smaller and less numerous than wild type cultures, while AD-KO osteoclasts were almost completely devoid of TRAP positive mononuclear cells. Female A-KO mice are osteopetrotic while male A- and D-KO mice of either sex had no significant in vivo skeletal phenotype, suggesting a sex-specific regulation of osteoclasts by MEF2A. Lastly, in vivo male AD-KO mice are osteopenic, indicating while MEF2 is required for M-CSF and RANKL-stimulated osteoclastogenesis in vitro, osteoclasts can form in the absence of MEF2 in vivo via a RANKL-alternative pathway.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Estrogen; HDACs; MEF2; Osteoclasts; Sex specific; Transcription factors

Mesh:

Substances:

Year:  2020        PMID: 32512162      PMCID: PMC7443313          DOI: 10.1016/j.bone.2020.115466

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  34 in total

1.  A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.

Authors:  U Dressel; P J Bailey; S C Wang; M Downes; R M Evans; G E Muscat
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  MEF2: a calcium-dependent regulator of cell division, differentiation and death.

Authors:  Timothy A McKinsey; Chun Li Zhang; Eric N Olson
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

3.  HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.

Authors:  Marc N Wein; Jordan Spatz; Shigeki Nishimori; John Doench; David Root; Philip Babij; Kenichi Nagano; Roland Baron; Daniel Brooks; Mary Bouxsein; Paola Divieti Pajevic; Henry M Kronenberg
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

4.  HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling.

Authors:  Zixue Jin; Wei Wei; HoangDinh Huynh; Yihong Wan
Journal:  Mol Endocrinol       Date:  2015-03-20

5.  MEF2D drives photoreceptor development through a genome-wide competition for tissue-specific enhancers.

Authors:  Milena M Andzelm; Timothy J Cherry; David A Harmin; Annabel C Boeke; Charlotte Lee; Martin Hemberg; Basil Pawlyk; Athar N Malik; Steven W Flavell; Michael A Sandberg; Elio Raviola; Michael E Greenberg
Journal:  Neuron       Date:  2015-03-19       Impact factor: 17.173

6.  HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.

Authors:  Zixue Jin; Wei Wei; Paul C Dechow; Yihong Wan
Journal:  Mol Endocrinol       Date:  2012-11-30

7.  IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.

Authors:  Gianluca Toraldo; Cristiana Roggia; Wei-Ping Qian; Roberto Pacifici; M Neale Weitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

8.  Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor.

Authors:  Eva van Rooij; Jens Fielitz; Lillian B Sutherland; Victor L Thijssen; Harry J Crijns; Michael J Dimaio; John Shelton; Leon J De Windt; Joseph A Hill; Eric N Olson
Journal:  Circ Res       Date:  2009-11-05       Impact factor: 17.367

9.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 10.  MEF2 transcription factors: developmental regulators and emerging cancer genes.

Authors:  Julia R Pon; Marco A Marra
Journal:  Oncotarget       Date:  2016-01-19
View more
  2 in total

1.  Histone deacetylase 5 is a phosphorylation substrate of protein kinase D in osteoclasts.

Authors:  Carina Mello Guimaraes Meyers; Samuel D Burciaga; Bora Faulkner; Parandis Kazemi; Jacob M Cohn; Kim C Mansky; Eric D Jensen
Journal:  Bone       Date:  2022-03-19       Impact factor: 4.626

2.  Antimicrobial and enzyme-responsive multi-peptide surfaces for bone-anchored devices.

Authors:  Nicholas G Fischer; Xi Chen; Kristina Astleford-Hopper; Jiahe He; Alex F Mullikin; Kim C Mansky; Conrado Aparicio
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.